Fayad Al-Haimus: The TOWAR Trial On Comaprison of Whole Blood vs Component Therapy in Trauma
Fayad Al-Haimus, Adult Thrombosis Fellow at McMaster University, shared a post on LinkedIn about a recent article by Jason L. Sperry et al, published in The New England Journal of Medicine (NEJM):
”Whole blood vs component therapy in trauma: does one save more lives?
A new trial has added to the evolving hemostatic resuscitation literature in trauma: the TOWAR trial (Prehospital Resuscitation with Type O Whole Blood for Trauma and Hemorrhage), recently published in NEJM Group.
Trial overview: Multicenter U.S. randomized trial including 1,020 trauma patients with suspected hemorrhagic shock requiring prehospital blood transfusion, randomized 2:1 to low-titer group O whole blood versus component therapy.
Key findings:
- No significant difference in 30-day mortality between whole blood and component therapy
- Outcomes were similar even when older whole blood products were used
- Reinforces the value of early blood administration in trauma care
The message may not be that ‘whole blood doesn’t work.’
Rather, this study suggests that in hemorrhagic trauma, getting blood to patients early may matter more than the exact product being delivered.”
Title: Prehospital Resuscitation with Type O Whole Blood for Trauma and Hemorrhage
Authors: Jason L. Sperry, Francis X. Guyette, Bryan A. Cotton, James F. Luther, Richard B. Utarnachitt, Matthew E. Kutcher, Brian J. Daley, Allan B. Peetz, Mayur B. Patel, Michael D. Goodman, Jeffrey A. Claridge, Nimitt Patel, Brian G. Harbrecht, Zain G. Hashmi, Ryan Zarychanski, Matthew D. Neal, Mark H. Yazer, Christian Martin-Gill, Laura E. Vincent, Ashley M. Harner, David E. Meyer, Andrew J. Latimer, Bryce R. Robinson, Catherine L. McKnight, William R. Hinckley, Keith R. Miller, Jan O. Jansen, Douglas Martin, Erin E. Fox, Bedda L. Rosario-Rivera, Stephen R. Wisniewski

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 9, 2026, 14:49Celebrating a Century of von Willebrand Disease Research and Care – Seminars in Thrombosis and Hemostasis
-
Jul 9, 2026, 14:38Valance Washington: International Hemostasis Community Prepares for GRC 2026
-
Jul 9, 2026, 14:27Dima Shulkin: Next-Generation AI Models Improve Early Sepsis Recognition
-
Jul 9, 2026, 14:12Omar Hajji: Seasonal Determinants of Mortality in Sepsis and Cardiogenic Shock
-
Jul 9, 2026, 13:54Hussein Yassine: Why Omega-3s May Fall Short in Preventing Alzheimer’s Disease
-
Jul 9, 2026, 13:16Olivier Mathieu: Innovating the Future of Hemostasis at ISTH 2026
-
Jul 9, 2026, 12:41Thomas Palmer-Dench: Hexokinase Controls Platelet Activation and Hemostasis
-
Jul 9, 2026, 12:19Paschalis Evangelidis: Join Our Special Issue on Thrombosis and Vascular Disorders
-
Jul 9, 2026, 12:16Fernanda Betti Solano: Could Iron Deficiency Be Affecting Your Sleep?